Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Business Times DC.

Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update
- Commenced market launch and first commercial sales of Symvess™ (acellular tissue engineered vessel-tyod) for the treatment of extremity vascular trauma - - Total revenues of $517,000 for quarter from sales and collaborative research agreement –...

FAVO Capital Announces Conversion of Super Voting Series C Shares to Common Stock
FORT LAUDERDALE, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- FAVO Capital, Inc. (OTC: FAVO), a publicly traded private credit firm specializing in merchant cash advances (MCAs) and revenue-based financing for underserved small and...

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Announced positive topline results from Phase 1...

Completing Half a Decade with Nero’s Heating & Air’s Trusted HVAC Solutions Across the DMV
HYATTSVILLE, MD, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- Since its inception in 2019, Nero’s Heating & Air has been a beacon of reliability and expertise for residents and businesses throughout the Washington, D.C., Maryland, and...

Terreno Realty Corporation Announces Lease in Woodinville, WA
Terreno Realty Corporation (NYSE:TRNO), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, announced today that it has executed a lease for 70,000 square feet in Woodinville, Washington with a designer and...

Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular...

Bright MLS April 2025 Housing Report: April showers and slower sales in the Mid-Atlantic housing market
North Bethesda, MD, May 12, 2025 (GLOBE NEWSWIRE) -- Buyer activity was sluggish in April with closed sales, pending sales and showing activity all lower than a year ago. A total of 18,615 transactions closed in April, which is an increase over...

MPOWER Financing Securitizes $313.2 Million of International Student Loans
MPOWER Financing ("MPOWER"), a mission-driven fintech firm and the leader in international student financing, today announced the completion of its second securitization, MPOWER Education Trust 2025-A ("MPOWR 2025-A"). The $313.2 million...

FiscalNote Reports First Quarter 2025 Financial Results
FiscalNote Holdings, Inc. (NYSE: NOTE) (“FiscalNote” or the “Company”), the leading AI-driven enterprise SaaS technology provider of policy and global intelligence, today reported financial results for the first quarter ended March 31, 2025. The...

PennantPark Floating Rate Capital Ltd. Announces Financial Results for the Second Quarter Ended March 31, 2025
MIAMI, May 12, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (NYSE: PFLT) announced today its financial results for the second quarter ended March 31, 2025. HIGHLIGHTS Quarter ended March 31, 2025 (Unaudited) ($ in millions,...

Mobile Infrastructure Reports First Quarter 2025 Financial Results
Mobile Infrastructure Corporation (NYSE American: BEEP), (“Mobile”, “Mobile Infrastructure” or the “Company”), owners of a diversified portfolio of parking assets throughout the United States, today reported results for the first quarter of 2025...

REPAY Reports First Quarter 2025 Financial Results
Repay Holdings Corporation (NASDAQ: RPAY) (“REPAY” or the “Company”), a leading provider of vertically-integrated payment solutions, today reported financial results for its first quarter ended March 31, 2025. First Quarter 2025 Financial...

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across portfolio of indications, including Phase 3...

Public Meeting Notice: Lincoln Road NE Protected Bike Lane Project Open House
FOR IMMEDIATE RELEASE Media Contacts Public Meeting Notice: Lincoln Road NE Protected Bike Lane Project Open House (Washington, DC) — The District Department of Transportation (DDOT) will host an open house to solicit public feedback on the...

LPRO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Open Lending Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Open Lending Corporation (NASDAQ: LPRO) securities between February 24, 2022 and March 31, 2025, inclusive (the “Class Period”), have until June 30, 2025 to seek...

Winthrop Estate Offered in DC Area’s Most Valuable Real Estate Market — Redefines Luxury and Holds International Appeal
This rare offering presents an opportunity to own a coveted estate and may attract the international buyer as currencies strengthen against the US dollar. MCLEAN, VA, UNITED STATES, May 11, 2025 /EINPresswire.com/ -- A premier estate blending...

Minister for Foreign Affairs Dr Vivian Balakrishnan's Meeting with United States Secretary of State and National Security Advisor Marco Rubio, 4 June 2025
Minister for Foreign Affairs Dr Vivian Balakrishnan met US Secretary of State and National Security Advisor Marco Rubio in Washington D.C. on 4 June 2025. Minister Balakrishnan and Secretary Rubio had a substantive and wide-ranging discussion on...

Commonwealth Financial Network Partners with Messina College, Creating Career Paths for First-Generation College Students
Commonwealth Financial Network®, a national RIA dedicated to providing financial advisors with holistic, integrated business solutions, has initiated a new partnership with Messina College, a two-year, all-residential degree program of Boston...

IMUNON Reports First Quarter 2025 Financial Results and Provides Business Update
First site initiated for Phase 3 OVATION 3 study of IMNN-001 in treatment of newly diagnosed advanced ovarian cancer New data from Phase 2 OVATION 2 study of IMNN-001 accepted for oral presentation at 2025 ASCO Annual Meeting Company to hold...

Cellectis Reports Financial Results for the First Quarter 2025
Lasme-cel (UCART22) Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025 Eti-cel (UCART20x22) Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r NHL) ongoing with readout expected in late...